Proteomic Charting of Imipenem Adaptive Responses in a Highly Carbapenem Resistant Clinical Enterobacter roggenkampii

Suruchi Nepal1, Sandra Maaß2, Stefano Grasso1

  • 1University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, University of Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB Groningen, The Netherlands.

Insights

Highly carbapenem-resistant Enterobacter cloacae complex bacteria, like E. roggenkampii ST232, reduce metabolic activity when treated with imipenem. This response conserves resources and limits damaging reactive oxygen species formation.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • The Enterobacter cloacae complex is a growing cause of hospital-acquired infections.
  • A carbapenem-resistant Enterobacter roggenkampii (ST232) highlights the need to understand resistance mechanisms.
  • Limited knowledge exists on how highly drug-resistant bacteria respond to antibiotics.

Purpose of the Study:

  • To investigate the adaptive responses of E. roggenkampii ST232 to imipenem.
  • To identify protein level changes induced by carbapenem exposure.

Main Methods:

  • Utilized stable isotope labeling of amino acids in cell culture (SILAC) for quantitative mass spectrometry.
  • Analyzed protein expression profiles of E. roggenkampii ST232 in response to imipenem.

Main Results:

  • Imipenem treatment induced significant alterations in protein levels.
  • Key affected pathways include cell wall biogenesis, central carbon metabolism, and respiration.
  • Changes in iron-sulfur cluster synthesis and metal homeostasis were also observed.

Conclusions:

  • E. roggenkampii ST232 downregulates metabolic activity under imipenem stress.
  • This adaptive strategy conserves resources and mitigates oxidative stress.
  • Understanding these responses offers insights into future antibiotic resistance evolution.